Shalaby M, Abdel-Reheim E, N Almanaa T, Alhaber L, Nabil A, Ahmed O
Regen Ther. 2024; 28:1-11.
PMID: 39678398
PMC: 11638607.
DOI: 10.1016/j.reth.2024.11.004.
Ando T, Kondo M, Asada-Yamada Y, Kawai M, Asano-Hayami E, Hayami T
Diabetol Int. 2024; 15(1):99-108.
PMID: 38264217
PMC: 10800311.
DOI: 10.1007/s13340-023-00651-z.
Gohari-Lasaki S, Sharafshah A, Abbaspour S, Keshavarz P
Int Ophthalmol. 2020; 40(3):639-647.
PMID: 31902046
DOI: 10.1007/s10792-019-01224-3.
Oguntibeju O, Aboua Y, Goboza M
Biomedicines. 2019; 7(3).
PMID: 31412679
PMC: 6784200.
DOI: 10.3390/biomedicines7030059.
Hamad M, Rahhal A, Dayyih W, Mallah E, Abu Dayyih A, Zakaria Z
J Pharm Bioallied Sci. 2019; 11(1):49-59.
PMID: 30906140
PMC: 6394163.
DOI: 10.4103/jpbs.JPBS_200_18.
Treatment Pattern and Factors Associated with Blood Pressure and Fasting Plasma Glucose Control among Patients with Type 2 Diabetes Mellitus in Police Referral Hospital in Ethiopia.
Shimels T, Abebaw M, Bilal A, Tesfaye T
Ethiop J Health Sci. 2019; 28(4):461-472.
PMID: 30607059
PMC: 6308733.
DOI: 10.4314/ejhs.v28i4.12.
'Knowing what matters in diabetes: healthier below 7': results of the campaign's first 10 years (part 1): participants with known type 2 diabetes.
Jacob S, Klimke-Hubner A, Dippel F, Hopfenmuller W
Cardiovasc Endocrinol. 2017; 5(1):14-20.
PMID: 28392972
PMC: 5367495.
DOI: 10.1097/XCE.0000000000000072.
Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines.
Cohen O, Valentine W
J Diabetes Sci Technol. 2016; 10(6):1388-1398.
PMID: 27621141
PMC: 5094344.
DOI: 10.1177/1932296816667747.
Self-directed learning can outperform direct instruction in the course of a modern German medical curriculum - results of a mixed methods trial.
Peine A, Kabino K, Spreckelsen C
BMC Med Educ. 2016; 16:158.
PMID: 27256081
PMC: 4891889.
DOI: 10.1186/s12909-016-0679-0.
Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.
Kostev K, Rockel T, Jacob L
J Diabetes Sci Technol. 2016; 11(1):117-122.
PMID: 27246670
PMC: 5375061.
DOI: 10.1177/1932296816651633.
Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the....
Pfohl M, Siegmund T, Pscherer S, Pegelow K, Seufert J
Vasc Health Risk Manag. 2015; 11:569-78.
PMID: 26604774
PMC: 4642811.
DOI: 10.2147/VHRM.S82720.
Treatment intensification using long-acting insulin -predictors of future basal insulin supported oral therapy in the DIVE registry.
Danne T, Bluhmki T, Seufert J, Kaltheuner M, Rathmann W, Beyersmann J
BMC Endocr Disord. 2015; 15:54.
PMID: 26446863
PMC: 4597397.
DOI: 10.1186/s12902-015-0051-0.
Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study.
Raum P, Lamparter J, Ponto K, Peto T, Hoehn R, Schulz A
PLoS One. 2015; 10(6):e0127188.
PMID: 26075604
PMC: 4468098.
DOI: 10.1371/journal.pone.0127188.
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy.
Gitt A, Bramlage P, Schneider S, Tschope D
Cardiovasc Diabetol. 2015; 14:13.
PMID: 25645672
PMC: 4324641.
DOI: 10.1186/s12933-015-0172-9.
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis.
Kostev K, Dippel F, Rathmann W
Diabetes Metab Syndr Obes. 2015; 8:45-8.
PMID: 25609990
PMC: 4298311.
DOI: 10.2147/DMSO.S76855.
Impact of information technology on the therapy of type-1 diabetes: a case study of children and adolescents in Germany.
Berndt R, Takenga C, Preik P, Kuehn S, Berndt L, Mayer H
J Pers Med. 2015; 4(2):200-17.
PMID: 25563223
PMC: 4263973.
DOI: 10.3390/jpm4020200.
Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.
Bramlage P, Gitt A, Schneider S, Deeg E, Tschope D
BMC Cardiovasc Disord. 2014; 14:162.
PMID: 25410473
PMC: 4247562.
DOI: 10.1186/1471-2261-14-162.
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.
Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K
Diabetes Technol Ther. 2014; 16(7):460-75.
PMID: 24716890
PMC: 4074758.
DOI: 10.1089/dia.2013.0302.
Real-life effectiveness and tolerability of vildagliptin and other oral glucose-lowering therapies in patients with type 2 diabetes in Germany.
Goke R, Bader G, Dworak M
Diabetes Ther. 2014; 5(1):183-91.
PMID: 24643724
PMC: 4065295.
DOI: 10.1007/s13300-014-0060-4.
The treatment of type 2 diabetes.
Pfeiffer A, Klein H
Dtsch Arztebl Int. 2014; 111(5):69-81.
PMID: 24612534
PMC: 3952010.
DOI: 10.3238/arztebl.2014.0069.
